Trial
NCT01522612
Colorectal Cancer (CRC) Cetuximab Elderly Frail
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
Merck KGaA, Darmstadt, Germany
Condition
Colorectal Cancer Metastatic
Intervention
Cetuximab
Why stopped
poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-10